Larimar Therapeutics (LRMR) Shares Outstanding (Entity) (2013 - 2026)
Larimar Therapeutics (LRMR) reported Shares Outstanding (Entity) of 103.88 million for Q2 2026, up 62.2% from 64.03 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2025, Larimar Therapeutics posted Shares Outstanding (Entity) of 83.09 million, up 30.2% from FY2024.
- Shares Outstanding (Entity) has increased for 11 consecutive years, with a five-year compound annual growth rate of 47.5% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 63.82 million in FY2024 (+45.3%), 43.91 million in FY2023 (+70.4%), 25.76 million in FY2022 (+45.5%) and 17.71 million in FY2021 (+49.0%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2013.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.4% in Q2 2025 to 144.3% in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Larimar Therapeutics | 331.39 Mn | -275.69 Mn | - | 103.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.88 Mn |
| Dec 31, 2025 | 83.09 Mn |
| Sep 30, 2025 | 85.59 Mn |
| Jun 30, 2025 | 64.03 Mn |
| Mar 31, 2025 | 64.03 Mn |
| Dec 31, 2024 | 63.82 Mn |
| Sep 30, 2024 | 63.81 Mn |
| Jun 30, 2024 | 63.80 Mn |
| Mar 31, 2024 | 63.80 Mn |
| Dec 31, 2023 | 43.91 Mn |
| Sep 30, 2023 | 43.91 Mn |
| Jun 30, 2023 | 43.27 Mn |
| Mar 31, 2023 | 43.27 Mn |
| Dec 31, 2022 | 25.76 Mn |
| Sep 30, 2022 | 22.23 Mn |
| Jun 30, 2022 | 17.71 Mn |
| Mar 31, 2022 | 17.71 Mn |
| Dec 31, 2021 | 17.71 Mn |
| Sep 30, 2021 | 17.71 Mn |
| Jun 30, 2021 | 15.37 Mn |
API Access
Larimar Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();